Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Pavlidis

Showing results (31-40 of 191) with videos related to

Pageof 20
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2009
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUPNicholas Pavlidis, George Pentheroudakis, George Plataniotis
British Journal of Cancer|February 12, 2020
Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?Elie Rassy, Tarek Assi, Nicholas Pavlidis
Journal of Advanced Research|August 11, 2015
A mini review on cancer of unknown primary site: A clinical puzzle for the oncologistsNicholas Pavlidis, Hussein Khaled, Rabab Gaafar
Cancer Treatment Reviews|December 13, 2005
Treatment of colorectal cancer in the elderly: a review of the literatureVassilis Golfinopoulos, George Pentheroudakis, Nicholas Pavlidis
European Journal of Clinical Investigation|May 10, 2021
Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primaryElie Rassy, Stergios Boussios, Nicholas Pavlidis
International Journal of Clinical Oncology|June 17, 2019
Familial cancer of unknown primaryElie Rassy, Joseph Kattan, Nicholas Pavlidis
Critical Reviews in Oncology/Hematology|September 4, 2007
Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safetyGeorge Lazaridis, George Pentheroudakis, Nicholas Pavlidis
European Journal of Clinical Investigation|March 14, 2013
Exploring the biology of cancer of unknown primary: breakthroughs and drawbacksKonstantinos Kamposioras, George Pentheroudakis, Nicholas Pavlidis
Lancet (London, England)|August 3, 2024
Molecular guided therapies: a practice-changing step forward in cancer of unknown primary managementElie Rassy, F Anthony Greco, Nicholas Pavlidis
Critical Reviews in Oncology/Hematology|October 26, 2011
Cancer prevalence and mortality in centenarians: a systematic reviewNicholas Pavlidis, Giorgio Stanta, Riccardo A Audisio
Pageof 20

Showing results (31-40 of 191) with videos related to

Sort By:
Pageof 20
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2009
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUPNicholas Pavlidis, George Pentheroudakis, George Plataniotis
British Journal of Cancer|February 12, 2020
Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?Elie Rassy, Tarek Assi, Nicholas Pavlidis
Journal of Advanced Research|August 11, 2015
A mini review on cancer of unknown primary site: A clinical puzzle for the oncologistsNicholas Pavlidis, Hussein Khaled, Rabab Gaafar
Cancer Treatment Reviews|December 13, 2005
Treatment of colorectal cancer in the elderly: a review of the literatureVassilis Golfinopoulos, George Pentheroudakis, Nicholas Pavlidis
European Journal of Clinical Investigation|May 10, 2021
Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primaryElie Rassy, Stergios Boussios, Nicholas Pavlidis
International Journal of Clinical Oncology|June 17, 2019
Familial cancer of unknown primaryElie Rassy, Joseph Kattan, Nicholas Pavlidis
Critical Reviews in Oncology/Hematology|September 4, 2007
Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safetyGeorge Lazaridis, George Pentheroudakis, Nicholas Pavlidis
European Journal of Clinical Investigation|March 14, 2013
Exploring the biology of cancer of unknown primary: breakthroughs and drawbacksKonstantinos Kamposioras, George Pentheroudakis, Nicholas Pavlidis
Lancet (London, England)|August 3, 2024
Molecular guided therapies: a practice-changing step forward in cancer of unknown primary managementElie Rassy, F Anthony Greco, Nicholas Pavlidis
Critical Reviews in Oncology/Hematology|October 26, 2011
Cancer prevalence and mortality in centenarians: a systematic reviewNicholas Pavlidis, Giorgio Stanta, Riccardo A Audisio
Pageof 20